Site Search
Professionals 507 results
Capabilities 82 results
Industry
The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative health care landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Health Care & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions.
Industry
Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations.
Practice Area
Government Program Fraud, False Claims Act & Qui Tam Litigation
Investigations and litigation involving alleged fraud against the government pose a significant and growing threat to organizations and individuals across all industries that engage directly or indirectly in business with federal, state, and/or local governments. The government makes aggressive use of its extensive criminal and civil investigatory powers to root out alleged fraud and abuse implicating government funds, including one of its most powerful civil enforcement tools—the federal False Claims Act (FCA)—and similar state false claims statutes.
Experience 187 results
Experience
|May 27, 2025
Experience
|May 9, 2025
An Am Law LOTW Shout Out-Worthy Gold Medal Victory In $Jenner
Insights & News 5,136 results
Investigations, Enforcement, & Compliance Alerts
|June 16, 2025
|3 Min Read
DOJ’s June 9, 2025 FCPA Guidelines: A Recalibration of U.S. Anti-Corruption Enforcement
The long-anticipated guidance released by the U.S. Department of Justice (DOJ) on June 9, 2025 (the Guidelines) reorients Foreign Corrupt Practices Act (FCPA) enforcement, shifting the DOJ’s focus to more centrally controlled, national-interest-driven anti-corruption misconduct. Below is an overview of the background and salient shifts driven by the Guidelines.
In the Media
|June 16, 2025
|2 Min Read
Tom Walsh Discusses How Hobbies Aid Legal Work With Texas Lawyer
Winston & Strawn Complex Commercial Litigation Practice Co-Chair Tom Walsh was featured in a Texas Lawyer article highlighting his hobbies outside of his work as a litigator, and how his hobbies aid him in his legal work. Tom has substantial experience successfully handling complex commercial litigation, class action, and patent litigation cases. Outside of the courtroom, Tom has spent 27 years as a radio play-by-play announcer for Jesuit College Preparatory School football, where he has called more than 200 high school football games, and has been involved in community theatre for more than three years. Tom started participating in community theatre with North Texas Performing Arts with his daughter. They have performed together in several musicals with Tom’s primary roles including the mayor in "The Music Man,” the Ghost of Christmas Present in "Scrooge," George Banks in "Mary Poppins," and, currently, King Arthur in "Camelot." He also took singing lessons to improve his skills.
Client Alert
|June 12, 2025
|3 Min Read
Oregon Enacts SB 951, Restricting PE-Backed MSOs in Physician Practice Transactions
On June 9, 2025, Oregon enacted Senate Bill 951 (SB 951), a sweeping new law significantly limiting how management services organizations (MSOs)—including those backed by private-equity firms—may engage with physician practices. The legislation targets traditional “friendly provider” models by restricting ownership and operational control of professional medical entities and voiding restrictive covenants. Investors must now reassess Oregon-based physician practice investments to ensure compliance by 2026 (for new MSOs) and 2029 (for existing ones). It’s noteworthy that this law will coexist with Oregon’s complicated health care transactions notice law, a law that requires a thorough review of certain health care transactions.
Other Results 126 results
Site Content
Site Content
The Jones Act, as used in the world of shipping is a law that reserves the transportation of goods between two points in the United States to qualified U.S.-flag vessels. This coastwise reservation law is named after its chief sponsor, Senator Wesley L. Jones. Similar laws apply to the transportation of passengers and reserve towing, dredging, and fishing in U.S. waters to qualified U.S.-flag vessels. Such vessels must be U.S. citizen-owned, U.S. citizen-crewed, U.S.-registered, and U.S.-built. Another law, also called the “Jones Act,” relates to merchant mariner injury recoveries.
Site Content
What Is the Securities Act of 1933?
The Securities Act of 1933 (as amended, the “Securities Act”) was passed to ensure that investors have financial and other important information about securities that are being sold publicly. It also bans the use of fraud, deceit, and misrepresentation in the sales of securities. The Securities Act, which is also referred to as the “truth in securities” law, is part of a legislative effort to govern and oversee the securities industry.